Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer

Published:2019-09-01 Issue:9 Volume:5 Page:1268
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Pietrantonio Filippo¹²,Morano Federica²,Corallo Salvatore²,Miceli Rosalba³,Lonardi Sara⁴,Raimondi Alessandra²,Cremolini Chiara⁵,Rimassa Lorenza⁶,Bergamo Francesca⁴,Sartore-Bianchi Andrea¹⁷,Tampellini Marco⁸,Racca Patrizia⁹,Clavarezza Matteo¹⁰,Berenato Rosa¹¹,Caporale Marta²,Antista Maria²,Niger Monica²,Smiroldo Valeria⁶,Murialdo Roberto¹²,Zaniboni Alberto¹³,Adamo Vincenzo¹¹,Tomasello Gianluca¹⁴,Giordano Monica¹⁵,Petrelli Fausto¹⁶,Longarini Raffaella¹⁷,Cinieri Saverio¹⁸,Falcone Alfredo⁵,Zagonel Vittorina⁴,Di Bartolomeo Maria²,de Braud Filippo¹²

Affiliation:

1. Oncology and Hemato-oncology Department, University of Milan, Milan, Italy

2. Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy

3. Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

4. Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy

5. Unit of Medical Oncology, Azienda Ospedaliero-Universitaria (AOU) Pisana, Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy

6. Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy

7. Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy

8. Department of Oncology, AOU San Luigi di Orbassano, University of Torino, Orbassano, Italy

9. Colorectal Cancer Unit, Medical Oncology Division 1, AOU Città della Salute e della Scienza, Torino, Italy

10. Medical Oncology Unit, Ente Ospedaliero Ospedali Galliera, Genoa, Italy

11. Medical Oncology Unit A.O. Papardo and Department of Human Pathology, University of Messina, Messina, Italy

12. Department of Internal Medicine, University of Genoa and IRCCS AOU San Martino-IST, Genoa, Italy

13. Medical Oncology Unit, Fondazione Poliambulanza, Brescia, Italy

14. Medical Oncology Unit, Azienda Socio-Sanitaria Territoriale (ASST) Ospedale di Cremona, Cremona, Italy

15. Medical Oncology Unit, Azienda Socio Sanitaria Territoriale Lariana, Como, Italy

16. Medical Oncology Unit, Oncology Department, ASST Bergamo Ovest, Treviglio, Italy

17. Medical Oncology Unit, Azienda Ospedaliera San Gerardo, Monza, Italy

18. Medical Oncology Unit, Ospedale Antonio Perrino, Brindisi, Italy

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2737075/jamaoncology_pietrantonio_2019_oi_190038.pdf

Reference29 articles.

1. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.;Van Cutsem;Ann Oncol,2016

2. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.;Douillard;N Engl J Med,2013

3. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.;Van Cutsem;N Engl J Med,2009

4. Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial.;Venook;JAMA,2017

5. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.;Heinemann;Lancet Oncol,2014

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases;Frontiers in Pharmacology;2024-07-26

2. Targeting the EGFR signalling pathway in metastatic colorectal cancer;The Lancet Gastroenterology & Hepatology;2024-07

3. Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial;ESMO Open;2024-07

4. Therapeutic strategies targeting the epidermal growth factor receptor signaling pathway in metastatic colorectal cancer;World Journal of Gastrointestinal Oncology;2024-06-15

5. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC;Frontiers in Surgery;2024-06-14